Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹31,623.1
₹67,197 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,647.4
₹33,069 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹577.6
₹9,091 Cr
Pharmaceuticals & Drugs
₹917.3
₹8,314 Cr
Pharmaceuticals & Drugs
₹472.2
₹4,310 Cr
Pharmaceuticals & Drugs
₹332.6
₹3,721 Cr
Pharmaceuticals & Drugs
₹117.7
₹3,022 Cr
Pharmaceuticals & Drugs
₹157.1
₹765 Cr
Pharmaceuticals & Drugs
₹855.5
₹488 Cr
Pharmaceuticals & Drugs
₹54.4
₹154 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,647.4
₹4,648 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹577.6
₹4,118 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹472.2
₹2,387 Cr
Pharmaceuticals & Drugs
₹917.3
₹2,115 Cr
Pharmaceuticals & Drugs
₹332.6
₹637 Cr
Pharmaceuticals & Drugs
₹117.7
₹222 Cr
Pharmaceuticals & Drugs
₹157.1
₹73 Cr
Pharmaceuticals & Drugs
₹31,623.1
₹6,409 Cr
Pharmaceuticals & Drugs
₹855.5
₹346 Cr
Pharmaceuticals & Drugs
₹54.4
₹474 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,647.4
₹920 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹577.6
₹344 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹917.3
₹272 Cr
Pharmaceuticals & Drugs
₹472.2
₹168 Cr
Pharmaceuticals & Drugs
₹117.7
₹145 Cr
Pharmaceuticals & Drugs
₹332.6
₹134 Cr
Pharmaceuticals & Drugs
₹157.1
₹3 Cr
Pharmaceuticals & Drugs
₹31,623.1
₹1,414 Cr
Pharmaceuticals & Drugs
₹855.5
₹17 Cr
Pharmaceuticals & Drugs
₹54.4
₹4 Cr

You may also like the below Video Courses